Thyroid disease and the heart.
暂无分享,去创建一个
[1] S. Olsson,et al. Long QT interval and ventricular tachycardia of "torsade de pointe" type in hypothyroidism. , 2009, Acta medica Scandinavica.
[2] W. Bremner,et al. Advances in male contraception. , 2008, Endocrine reviews.
[3] B. Gloss,et al. Adeno-associated virus-mediated expression of thyroid hormone receptor isoforms-alpha1 and -beta1 improves contractile function in pressure overload-induced cardiac hypertrophy. , 2007, Endocrinology.
[4] J. Weaver,et al. The beneficial effect of L-thyroxine on cardiovascular risk factors, endothelial function, and quality of life in subclinical hypothyroidism: randomized, crossover trial. , 2007, The Journal of clinical endocrinology and metabolism.
[5] L. Vatten,et al. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study. , 2007, The Journal of clinical endocrinology and metabolism.
[6] F. Bogazzi,et al. Glucocorticoid response in amiodarone-induced thyrotoxicosis resulting from destructive thyroiditis is predicted by thyroid volume and serum free thyroid hormone concentrations. , 2007, The Journal of clinical endocrinology and metabolism.
[7] J. Franklyn,et al. Cardiovascular manifestations of hyperthyroidism before and after antithyroid therapy: a matched case-control study. , 2007, Journal of the American College of Cardiology.
[8] A. Divani,et al. Free thyroxine index and risk of stroke: results from the National Health and Nutrition Examination Survey Follow-up Study. , 2006, Medical Science Monitor.
[9] N. Takasu. [Thyroid hormone and the cardiovascular system]. , 2006, Nihon rinsho. Japanese journal of clinical medicine.
[10] Samuel Wann,et al. [Guidelines for the management of patients with atrial fibrillation. Executive summary]. , 2006, Revista espanola de cardiologia.
[11] U. John,et al. The association between subclinical hyperthyroidism and blood pressure in a population-based study , 2006, Journal of hypertension.
[12] P. Leedman,et al. Subclinical thyroid dysfunction and blood pressure: a community‐based study , 2006, Clinical endocrinology.
[13] J. Romaldini,et al. Management of amiodarone‐induced thyrotoxicosis in Latin America: an electronic survey , 2006, Clinical endocrinology.
[14] Thomas S. Scanlan,et al. Rapid nongenomic actions of thyroid hormone , 2006, Proceedings of the National Academy of Sciences.
[15] D. Ascheim,et al. Thyroid hormone and heart failure , 2006, Current heart failure reports.
[16] I. Klein,et al. Role of Thyroid Disease in the Development of Statin-Induced Myopathy , 2006 .
[17] J. Gujral,et al. Hyperthyroidism: A Secondary Cause of Isolated Systolic Hypertension , 2006, Journal of clinical hypertension.
[18] R. Delsignore,et al. Pulmonary hypertension is frequent in hyperthyroidism and normalizes after therapy. , 2006, European journal of internal medicine.
[19] E. Vittinghoff,et al. Subclinical hypothyroidism and the risk of coronary heart disease: a meta-analysis. , 2006, The American journal of medicine.
[20] Y. Paran,et al. Pulmonary hypertension and predominant right heart failure in thyrotoxicosis. , 2006, Resuscitation.
[21] L. Fried,et al. Thyroid status, cardiovascular risk, and mortality in older adults. , 2006, JAMA.
[22] J. García-Estañ,et al. Vascular and renal function in experimental thyroid disorders. , 2006, European journal of endocrinology.
[23] A. Gerdes,et al. Thyroid hormone activates Akt and prevents serum starvation-induced cell death in neonatal rat cardiomyocytes. , 2005, Journal of molecular and cellular cardiology.
[24] Irwin Klein,et al. Effect of serum triiodothyronine on regulation of cardiac gene expression: role of histone acetylation. , 2005, American journal of physiology. Heart and circulatory physiology.
[25] J. Harney,et al. Type 2 iodothyronine deiodinase is the major source of plasma T3 in euthyroid humans. , 2005, The Journal of clinical investigation.
[26] G. Kahaly,et al. Thyroid hormone action in the heart. , 2005, Endocrine reviews.
[27] W. So,et al. Thyrotoxicosis and pulmonary hypertension. , 2005, The American journal of medicine.
[28] J. Franklyn,et al. Thyroid function and mortality in patients treated for hyperthyroidism. , 2005, JAMA.
[29] O. Kwon,et al. Moyamoya disease associated with Graves disease: special considerations regarding clinical significance and management. , 2005, Journal of neurosurgery.
[30] J. Chung,et al. Severe coronary artery spasm can be associated with hyperthyroidism , 2005, Coronary artery disease.
[31] I. Klein,et al. Effect of triiodothyronine on gene transcription during cardiopulmonary bypass in infants with ventricular septal defect. , 2005, The American journal of cardiology.
[32] Henry Völzke,et al. The association of thyroid function with cardiac mass and left ventricular hypertrophy. , 2005, The Journal of clinical endocrinology and metabolism.
[33] A. L'Abbate,et al. Triiodothyronine levels for risk stratification of patients with chronic heart failure. , 2005, The American journal of medicine.
[34] A. Bardají,et al. Cardiovascular abnormalities in hyperthyroidism: a prospective Doppler echocardiographic study. , 2005, The American journal of medicine.
[35] P. Vestergaard,et al. Hyperthyroidism and risk of atrial fibrillation or flutter: a population-based study. , 2004, Archives of internal medicine.
[36] V. Palmieri,et al. Myocardial contractility and total arterial stiffness in patients with overt hyperthyroidism: acute effects of beta1-adrenergic blockade. , 2004, European journal of endocrinology.
[37] L. Agellon,et al. Regulation of the human cholesterol 7alpha-hydroxylase gene (CYP7A1) by thyroid hormone in transgenic mice. , 2004, Endocrinology.
[38] J. Franklyn,et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. , 2004, JAMA.
[39] I. Klein,et al. Thyroid hormone and blood pressure regulation , 2003, Current hypertension reports.
[40] F. Haddad,et al. Role of Antisense RNA in Coordinating Cardiac Myosin Heavy Chain Gene Switching* , 2003, Journal of Biological Chemistry.
[41] L. Ghiadoni,et al. Impaired endothelium-dependent vasodilatation in subclinical hypothyroidism: beneficial effect of levothyroxine therapy. , 2003, The Journal of clinical endocrinology and metabolism.
[42] P. Ladenson,et al. Hypothyroidism and atherosclerosis. , 2003, The Journal of clinical endocrinology and metabolism.
[43] J. Laragh,et al. Relevance of the plasma renin hormonal control system that regulates blood pressure and sodium balance for correctly treating hypertension and for evaluating ALLHAT. , 2003, American journal of hypertension.
[44] L. Demers,et al. Laboratory medicine practice guidelines: laboratory support for the diagnosis and monitoring of thyroid disease , 2003, Clinical endocrinology.
[45] M. Christ-Crain,et al. Elevated C-reactive protein and homocysteine values: cardiovascular risk factors in hypothyroidism? A cross-sectional and a double-blind, placebo-controlled trial. , 2003, Atherosclerosis.
[46] F. R. Miller,et al. Disorders of the Thyroid , 2003 .
[47] F. B. Davis,et al. Nongenomic actions of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.
[48] Mathew R. Williams,et al. Thyroidectomy using local anesthesia in critically ill patients with amiodarone-induced thyrotoxicosis: a review and description of the technique. , 2002, Thyroid : official journal of the American Thyroid Association.
[49] H. Nakazawa,et al. Hyperthyroidism and the management of atrial fibrillation. , 2002, Thyroid : official journal of the American Thyroid Association.
[50] W. Dillmann. Cellular action of thyroid hormone on the heart. , 2002, Thyroid : official journal of the American Thyroid Association.
[51] L. Duntas. Thyroid disease and lipids. , 2002, Thyroid : official journal of the American Thyroid Association.
[52] E. Ferrannini,et al. Lipoprotein profile in subclinical hypothyroidism: response to levothyroxine replacement, a randomized placebo-controlled study. , 2002, The Journal of clinical endocrinology and metabolism.
[53] B. Biondi,et al. Effects of thyroid hormone on cardiac function: the relative importance of heart rate, loading conditions, and myocardial contractility in the regulation of cardiac performance in human hyperthyroidism. , 2002, The Journal of clinical endocrinology and metabolism.
[54] P. Larsen,et al. Biochemistry, cellular and molecular biology, and physiological roles of the iodothyronine selenodeiodinases. , 2002, Endocrine reviews.
[55] B. Biondi,et al. Impact of Hyperthyroidism and Its Correction on Vascular Reactivity in Humans , 2001, Circulation.
[56] J. Auer,et al. Subclinical hyperthyroidism as a risk factor for atrial fibrillation. , 2001, American heart journal.
[57] V. Fuster,et al. ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference , 2001, Circulation.
[58] E. Kucharz,et al. Influence of short-time application of a low sodium diet on blood pressure in patients with hyperthyroidism or hypothyroidism during therapy. , 2001, American journal of hypertension.
[59] J. Franklyn,et al. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study , 2001, The Lancet.
[60] L. Braverman,et al. The effects of amiodarone on the thyroid. , 2001, Endocrine reviews.
[61] W. Wiersinga,et al. Endocrine factors related to changes in total peripheral vascular resistance after treatment of thyrotoxic and hypothyroid patients. , 2001, European journal of endocrinology.
[62] B. Biondi,et al. Endogenous subclinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. , 2000, The Journal of clinical endocrinology and metabolism.
[63] R. Koenig,et al. Gene Regulation by Thyroid Hormone , 2000, Trends in Endocrinology & Metabolism.
[64] W. Linssen,et al. Neuromuscular findings in thyroid dysfunction: a prospective clinical and electrodiagnostic study , 2000, Journal of neurology, neurosurgery, and psychiatry.
[65] G. Canaris,et al. The Colorado thyroid disease prevalence study. , 2000, Archives of internal medicine.
[66] A. Hofman,et al. Subclinical Hypothyroidism Is an Independent Risk Factor for Atherosclerosis and Myocardial Infarction in Elderly Women: The Rotterdam Study , 2000, Annals of Internal Medicine.
[67] N. Ishikawa,et al. Is there a place for the late cardioversion of atrial fibrillation? A long-term follow-up study of patients with post-thyrotoxic atrial fibrillation. , 2000, European heart journal.
[68] M. Lazar,et al. Transcriptional Repression by Nuclear Hormone Receptors , 2000, Trends in Endocrinology & Metabolism.
[69] A. Arroliga,et al. High prevalence of hypothyroidism in patients with primary pulmonary hypertension. , 1999, The American journal of the medical sciences.
[70] M. Alevizaki,et al. Mitral valve prolapse in autoimmune thyroid disease: an index of systemic autoimmunity? , 1999, Thyroid : official journal of the American Thyroid Association.
[71] P. Larsen,et al. Thyroid hormone regulates hyperpolarization-activated cyclic nucleotide-gated channel (HCN2) mRNA in the rat heart. , 1999, Circulation research.
[72] D. Mckinnon,et al. Distribution and prevalence of hyperpolarization-activated cation channel (HCN) mRNA expression in cardiac tissues. , 1999, Circulation research.
[73] J. Franklyn,et al. Mortality after the treatment of hyperthyroidism with radioactive iodine. , 1998, The New England journal of medicine.
[74] E. Park,et al. Thyroid hormone induces beta1-adrenergic receptor gene transcription through a direct repeat separated by five nucleotides. , 1997, Journal of molecular and cellular cardiology.
[75] L. Leinwand,et al. Myosin heavy chain gene expression in human heart failure. , 1997, The Journal of clinical investigation.
[76] B. Groves,et al. Changes in gene expression in the intact human heart. Downregulation of alpha-myosin heavy chain in hypertrophied, failing ventricular myocardium. , 1997, The Journal of clinical investigation.
[77] K. Ojamaa,et al. Alterations in cardiac contractility and gene expression during low-T3 syndrome: prevention with T3. , 1997, American journal of physiology. Endocrinology and metabolism.
[78] I. Klein,et al. Thyroid hormone and the cardiovascular system. , 1997, The New England journal of medicine.
[79] F. Sellke,et al. The Direct Vasomotor Effect of Thyroid Hormones on Rat Skeletal Muscle Resistance Arteries , 1997, Anesthesia and analgesia.
[80] D. A. Meier. Werner and Ingbar's The Thyroid , 1997 .
[81] S. Liggett,et al. Effects of thyroid hormone on cardiac beta-adrenergic responsiveness in conscious baboons. , 1997, Circulation.
[82] T. Visser,et al. Uptake of thyroid hormones in neonatal rat cardiac myocytes. , 1996, Endocrinology.
[83] F. Bogazzi,et al. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. , 1996, The Journal of clinical endocrinology and metabolism.
[84] A. Pezzarossa,et al. Power spectral analysis of heart rate in hyperthyroidism. , 1996, The Journal of clinical endocrinology and metabolism.
[85] S. Connolly,et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. , 1996, Archives of internal medicine.
[86] S. Thomas,et al. Thyroid hormone treatment after coronary-artery bypass surgery. , 1995, The New England journal of medicine.
[87] P. Caron. [Effects of amiodarone on thyroid function]. , 1995, Presse medicale.
[88] Y. Hirata,et al. Hormonal regulation of rat adrenomedullin gene in vasculature. , 1995, Endocrinology.
[89] R. D'Agostino,et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. , 1994, The New England journal of medicine.
[90] F. Epstein,et al. The molecular basis of thyroid hormone action. , 1994, The New England journal of medicine.
[91] I. Klein,et al. Beta-Adrenergic Receptor Blocking Drugs in the Management of Hyperthyroidism , 1994 .
[92] G S Levey,et al. Treatment of Hyperthyroid Disease , 1994, Annals of Internal Medicine.
[93] É. Kiss,et al. Thyroid hormone-induced alterations in phospholamban protein expression. Regulatory effects on sarcoplasmic reticulum Ca2+ transport and myocardial relaxation. , 1994, Circulation research.
[94] C. Glass,et al. Delineation of three different thyroid hormone-response elements in promoter of rat sarcoplasmic reticulum Ca2+ATPase gene. Demonstration that retinoid X receptor binds 5' to thyroid hormone receptor in response element 1. , 1994, The Journal of biological chemistry.
[95] D. Krikler,et al. Heart disease: A textbook of cardiovascular medicine , 1992 .
[96] J. A. Franklyn,et al. Treatment of amiodarone induced thyrotoxicosis with carbimazole alone and continuation of amiodarone. , 1992, BMJ.
[97] P. Ladenson,et al. Reversible alterations in myocardial gene expression in a young man with dilated cardiomyopathy and hypothyroidism. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[98] B. Weintraub,et al. Spectrum of subclinical and overt hypothyroidism: effect on thyrotropin, prolactin, and thyroid reserve, and metabolic impact on peripheral target tissues. , 1992, The American journal of medicine.
[99] I. Klein,et al. Enhanced left ventricular diastolic function in hyperthyroidism: noninvasive assessment and response to treatment. , 1991, The Journal of clinical endocrinology and metabolism.
[100] M. Lazar,et al. Nuclear thyroid hormone receptors. , 1990, The Journal of clinical investigation.
[101] M. Luu,et al. Altered thyroid hormone metabolism in advanced heart failure. , 1990, Journal of the American College of Cardiology.
[102] M. Bentivoglio,et al. The effect of diltiazem, a calcium channel-blocking drug, on cardiac rate and rhythm in hyperthyroid patients. , 1988, Archives of internal medicine.
[103] F I Gilbert,et al. Graves' Disease: Influence of Age on Clinical Findings , 1988 .
[104] I. Klein,et al. Effects of thyroid hormone on cardiac size and myosin content of the heterotopically transplanted rat heart. , 1986, The Journal of clinical investigation.
[105] D. Kim,et al. Effects of thyroid hormone on sodium pump sites, sodium content, and contractile responses to cardiac glycosides in cultured chick ventricular cells. , 1984, The Journal of clinical investigation.
[106] J. Amico,et al. Clinical and chemical assessment of thyroid function during therapy with amiodarone. , 1984, Archives of internal medicine.
[107] A. Toft,et al. Abnormal left ventricular function in hyperthyroidism: evidence for a possible reversible cardiomyopathy. , 1982, The New England journal of medicine.
[108] A. Khaleeli,et al. Factors affecting resolution of pericardial effusions in primary hypothyroidism: a clinical, biochemical and echocardiographic study , 1982, Postgraduate medical journal.
[109] A. Soutar,et al. Defects of receptor-mediated low density lipoprotein catabolism in homozygous familial hypercholesterolemia and hypothyroidism in vivo. , 1981, Proceedings of the National Academy of Sciences of the United States of America.
[110] E W Bough,et al. Noninvasive evaluation of cardiac function in hypothyroidism. Response to gradual thyroxine replacement. , 1977, The New England journal of medicine.
[111] P. Fraser,et al. Grades of hypothyroidism. , 1973, British medical journal.
[112] A. Steinberg. Myxedema and coronary artery disease--a comparative autopsy study. , 1968, Annals of internal medicine.
[113] R. Segal,et al. Thyrocardiac disease and its management with radioactive iodine I-131. , 1961, JAMA.
[114] Samuel Wann,et al. AMERICAN COLLEGE OF CARDIOLOGY, AMERICAN HEART ASSOCIATION AND EUROPEAN SOCIETY OF CARDIOLOGY GUIDELINES (2006) FOR THE MANAGEMENT OF PATIENTS WITH ATRIAL FIBRILLATION (ENDING) , 2007 .
[115] E. Gaitan,et al. Disorders of the Thyroid , 1992 .
[116] P. Trzepacz,et al. Hyperthyroid myopathy and the response to treatment. , 1991, Thyroid : official journal of the American Thyroid Association.
[117] P. Petersen,et al. Stroke in thyrotoxicosis with atrial fibrillation. , 1988, Stroke.
[118] Christian Komusiewicz,et al. Hyper. , 1988, Nursing standard (Royal College of Nursing (Great Britain) : 1987).
[119] R. Volpe. Immunoregulation in autoimmune thyroid disease. , 1987, The New England journal of medicine.
[120] T. Parkin,et al. Treatment of heart disease associated with myxedema. , 1961, Progress in cardiovascular diseases.